Rapid Low-Cost Paper-based Biodosimetry that reveals individual organ injuries
快速低成本纸基生物剂量测定可揭示个体器官损伤
基本信息
- 批准号:10571697
- 负责人:
- 金额:$ 60.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-02-01 至 2025-01-31
- 项目状态:未结题
- 来源:
- 关键词:AccidentsAcuteAddressAffectAnimalsArizonaBiologicalBiological MarkersBiological ModelsBloodBone MarrowCategoriesCellsClassificationCollaborationsCollectionCoupledData AnalysesData SetDevelopmentDevicesDiagnostic testsDoseDropsEnsureExposure toFutureGene ChipsGene ExpressionGene Expression ProfilingGenesGenetic TranscriptionGenomic approachHealth PersonnelHourHumanIndividualInjuryIonizing radiationLaboratoriesLiteratureLymphocyteLymphocyte CountLymphocyte DepletionMeasuresMedicalMethodsModelingMusNormal RangeNuclear AccidentsNucleic Acid Amplification TestsOrganPaperPatientsPopulationProbabilityRNARadiationRadiation AccidentsRadiation Dose UnitRadiation InjuriesRadiation ToleranceRadiation exposureRadiation-Induced Gene ExpressionRecommendationResource-limited settingResourcesRiskSamplingSpecificityTechniquesTechnologyTerrorismTestingTherapeutic InterventionTimeTissuesTriageUniversitiesWorkZika Virusabsorptionbiodosimetrybiomarker panelbiomarker selectionclassification algorithmcohortcostdata curationdesignexperiencehuman modelimprovedin vivoin vivo Modelnext generation sequencingnovel strategiesorgan injuryperipheral bloodpersonalized diagnosticspoint of carepoint of care testingpopulation basedpredictive markerradiation absorbed doseresponserisk predictionscreeningspecific biomarkerstool
项目摘要
Abstract:
Increasing threats of nuclear accidents and/or terrorism have triggered an urgent need for the
ability to confirm and quantify absorbed radiation doses in a large population exposed to an
unknown amount of unintended radiation. An effective triage method has the potential to save
thousands of lives. To best utilize the available resources, stepwise triage recommends first
using a point-of-care (POC) test that distinguishes between the non-exposed and the exposed
population, followed by an assessment of those exposed using high throughput quantitative
analysis methods to estimate their absorbed doses of radiation. The ideal POC test will predict
acute and delayed radiation injuries to major organs, like bone marrow. To estimate the
absorbed dose, biodosimetry measures host biological responses to ionizing radiation. The
expression of specific genes alters based on the dose of radiation. Here we use the expression
levels of these radiation-responsive genes as biomarkers of exposure to radiation. Previously,
we used genomic approaches coupled with an in vivo NHP model to identify many radiation
responsive genes and develop a high throughput laboratory test to detect and quantify absorbed
dose of radiation within 7 days of post exposure. A new analysis of these data reveals a subset
of biomarkers that distinguish exposed from non-exposed individuals. Moreover, one of the
hallmarks of radiation exposure is a rapid decay in the total number of lymphocytes. This new
panel of biomarkers can quantitatively predict a significant drop in the lymphocyte count at 7
days post exposure, only 24 hours post exposure. We also have technology for converting our
gene expression assays into a low-cost paper-based POC test, compatible with screening a
large population. By combining our capabilities and currently available biomarkers, we intend to
develop a low-cost POC test that; 1) identifies individuals exposed to unintended radiation; 2)
qualitatively classifies individuals based on their absorbed dose of radiation; 3) predicts the risk
of serious bone marrow injury by calculating their future day 7 lymphocyte counts on day 1. We
will execute our project study plan in three steps. First, we will select the best subset of
biomarkers by analyzing gene expression data sets and curating literature. Second, we will
adapt our paper-based, low-cost, POC test to the critical expression levels of these markers.
Finally, we will validate our test and biomarkers using independent unknown samples.
摘要:
核事故和/或恐怖主义的威胁日益增加,迫切需要
确认和量化暴露于辐射的大量人群中吸收的辐射剂量的能力
未知数量的意外辐射有效的分诊方法有可能挽救
成千上万的生命。为了最好地利用现有资源,逐步分流建议首先
使用区分未暴露和暴露的即时(POC)测试,
人群,然后使用高通量定量
分析方法,以估计其吸收的辐射剂量。理想的POC测试将预测
急性和延迟辐射损伤的主要器官,如骨髓。估计
生物剂量学测量宿主对电离辐射的生物反应。的
特定基因的表达根据辐射剂量而改变。这里我们用这个表达
这些辐射反应基因的水平作为暴露于辐射的生物标志物。在此之前,
我们使用基因组方法结合体内NHP模型来识别许多辐射,
响应基因,并开发高通量实验室测试,以检测和量化吸收
在暴露后7天内接受辐射剂量。对这些数据的新分析揭示了一个子集
区分暴露个体和非暴露个体的生物标志物。此外,
辐射暴露的标志是淋巴细胞总数的迅速衰减。这个新
一组生物标志物可以定量预测淋巴细胞计数在7
暴露后24天,暴露后24小时。我们也有技术将我们的
将基因表达检测转化为低成本的纸基POC检测,与筛选和
人口众多。通过结合我们的能力和目前可用的生物标志物,我们打算
开发一种低成本的POC测试; 1)识别暴露于意外辐射的个人; 2)
根据吸收的辐射剂量对个人进行定性分类; 3)预测风险
通过计算第1天的未来第7天淋巴细胞计数来评估严重骨髓损伤。我们
我们将分三个步骤执行我们的项目研究计划。首先,我们将选择最佳子集,
生物标志物通过分析基因表达数据集和整理文献。二是
使我们的基于纸的、低成本的POC测试适应这些标志物的关键表达水平。
最后,我们将使用独立的未知样本验证我们的测试和生物标志物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOSHUA LABAER其他文献
JOSHUA LABAER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOSHUA LABAER', 18)}}的其他基金
Multiplex In-Solution Protein Array (MISPA) for high throughput, quantitative, early profiling of pathogen-induced head and neck
多重溶液内蛋白质芯片 (MISPA) 用于对病原体引起的头颈部进行高通量、定量、早期分析
- 批准号:
10713928 - 财政年份:2023
- 资助金额:
$ 60.52万 - 项目类别:
High-throughput immunoproteomics for cancer biomarker discovery
用于癌症生物标志物发现的高通量免疫蛋白质组学
- 批准号:
10688269 - 财政年份:2022
- 资助金额:
$ 60.52万 - 项目类别:
High-throughput immunoproteomics for cancer biomarker discovery
用于癌症生物标志物发现的高通量免疫蛋白质组学
- 批准号:
10487345 - 财政年份:2022
- 资助金额:
$ 60.52万 - 项目类别:
NIGMS National and Regional Resources - DNASU
NIGMS 国家和地区资源 - DNASU
- 批准号:
10238934 - 财政年份:2020
- 资助金额:
$ 60.52万 - 项目类别:
Rapid Low-Cost Paper-based Biodosimetry that reveals individual organ injuries
快速低成本纸基生物剂量测定可揭示个体器官损伤
- 批准号:
10349434 - 财政年份:2020
- 资助金额:
$ 60.52万 - 项目类别:
NIGMS National and Regional Resources - DNASU
NIGMS 国家和地区资源 - DNASU
- 批准号:
10400460 - 财政年份:2020
- 资助金额:
$ 60.52万 - 项目类别:
NIGMS National and Regional Resources - DNASU
NIGMS 国家和地区资源 - DNASU
- 批准号:
10025623 - 财政年份:2020
- 资助金额:
$ 60.52万 - 项目类别:
NIGMS National and Regional Resources - DNASU
NIGMS 国家和地区资源 - DNASU
- 批准号:
10454321 - 财政年份:2020
- 资助金额:
$ 60.52万 - 项目类别:
Rapid Low-Cost Paper-based Biodosimetry that reveals individual organ injuries
快速低成本纸基生物剂量测定可揭示个体器官损伤
- 批准号:
10092103 - 财政年份:2020
- 资助金额:
$ 60.52万 - 项目类别:
NIGMS National and Regional Resources - DNASU
NIGMS 国家和地区资源 - DNASU
- 批准号:
10797096 - 财政年份:2020
- 资助金额:
$ 60.52万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 60.52万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 60.52万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 60.52万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 60.52万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 60.52万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 60.52万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 60.52万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 60.52万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 60.52万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 60.52万 - 项目类别:
Operating Grants